Los Angeles ranked as “Top Ten” region for biopharma clusters

In the latest ranking of top cities for biopharma development, the publication Genetics and Engineering biotechnology news (GEN) reports that Los Angeles is ranked number 9 among U.S. regions.

GEN ranks regions based on five criteria:

  • NIH funding—Taken from the publicly available NIH RePORT database, for the current federal fiscal year, from its start on October 1, 2015, through March 27, 2016.
  • Venture Capital (VC) funding—Taken from 2015 figures furnished by the publicly available MoneyTree Report.
  • Patents—Based on the number of patents containing the word “biotechnology” awarded since 1976 in namesake cities and suburbs where key companies are located.
  • Lab space—Based on total-size-of-market figures, in millions of square feet, furnished by the commercial real estate brokerage JLL in its Life Sciences Cluster Reports for 2015.

The summary also notes the strong anchors of academia and research such as the University of Southern California, and its proposed biotech park adjacent to the Health Sciences Campus.